A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy Subjects

Inclusion Criteria: * Male or female non-smoking subject. * A body weight ≤ 120 kg and a BMI of 18.5-29.9 kg/m², inclusive. * Good health as determined by lack of clinically significant abnormalities in the health assessments performed at screening, as deemed by the Investigator (or designee). * Able and willing to comply with protocol restrictions and required study procedures. Exclusion Criteria: * History of allergy, hypersensitivity or idiosyncrasy to selegiline or other monoamine oxidase inhibitors (MAOIs), EMSAM® or any of its components, including glues/adhesives, or history of any drug hypersensitivity or intolerance that, in the opinion of the Investigator, would compromise the safety of the subject or integrity of the study. * Presence of any skin condition such as scratches, cuts, rash, scars, abrasions, excessive hair, tattoos or similar embodiments, moles, recently shaved skin, uneven skin texture, sunburned skin, or excessively oily skin at the application areas that, in the opinion of the Investigator, may affect the application or adhesion of the study patch or the systemic absorption of selegiline from the patch. * History or presence of any current dermatological condition such as atopy, psoriasis, eczema, chronic or atopic dermatitis, vitiligo, or urticaria which, in the opinion of the Investigator, would compromise the safety of the subject or the integrity of the study. * Personal (or immediate family history, as deemed relevant by the Investigator) of…